Table 3.
Assay Aa | Assay Bb | |||
---|---|---|---|---|
Compound | Kic | n | Kic | n |
11 | nbd | 3 | nbe | 3 |
15 | nbd | 3 | nbe | 3 |
MSH(4) | 1.9 ± 0.55 μM | 5 | 0.76 ± 0.04 μM | 4 |
14 | 2.7 ± 0.21 μM | 5 | 0.82 ± 0.26 μM | 3 |
16a | ndf | 1.7 ± 0.39 μM | 4 | |
16b | ndf | 1.2 ± 0.38 μM | 6 | |
16c | ndf | 0.84 ± 0.10 μM | 4 | |
16d | ndf | 0.52 ± 0.02 μM | 6 | |
16e | 2.2 ± 0.17 μM | 4 | 0.22 ± 0.06 μM | 4 |
This assay employed probe 17.
This assay employed probe 18.
Ki values were calculated using the equation Ki = EC50/(1 + ([ligand]/KD)) where [ligand] refers to the concentration of probe used as the labeled competed ligand. For probe 17, [ligand] = 10 nM and KD = 18.8 nM. For probe 18, [ligand] = 0.5 μM and KD = 9.1 μM. The value given represents the average of n independent competition binding experiments, each done in quadruplicate.
This compound was unable to prevent probe 17 from binding in the concentration range tested (10−5–10−12 M in serine amide).
This compound was unable to prevent probe 18 from binding in the concentration range tested (10−5–10−12 M in serine amide).
Not determined.